Entera Bio ENTX
NASDAQ ENTX
$3.23 +0.01 (+0.31%)
At close: Aug 21, 2026 · 4:00 PM EDT

Entera Bio (ENTX) Property, Plant & Equipment (Net) (2017 - 2026)

Entera Bio (ENTX) Property, Plant & Equipment (Net) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Entera Bio 161.44 Mn 150.13 Mn - 121,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 121,000.00
Jun 30, 2026 121,000.00
Mar 31, 2026 127,000.00
Mar 31, 2026 127,000.00
Dec 31, 2025 134,000.00
Dec 31, 2025 134,000.00
Sep 30, 2025 114,000.00
Sep 30, 2025 114,000.00
Jun 30, 2025 79,000.00
Jun 30, 2025 79,000.00
Mar 31, 2025 57,000.00
Mar 31, 2025 57,000.00
Dec 31, 2024 57,000.00
Dec 31, 2024 57,000.00
Sep 30, 2024 65,000.00
Sep 30, 2024 65,000.00
Jun 30, 2024 76,000.00
Jun 30, 2024 76,000.00
Mar 31, 2024 87,000.00
Mar 31, 2024 87,000.00